JPN-SAKE-&-SHOCHU-MAKERS
4.1.2023 02:01:36 CET | Business Wire | Press release
The Japan Sake and Shochu Makers Association (JSS), a non-profit organization created by the producers of Japan’s two main alcoholic beverages, sake and shochu, is hosting the second annual Sake Future Summit. The event will be held across two days (January 8th and 15th). Each day will consist of 4 online sessions between 8:00 am and 1:00 pm (JST). JSS has invited leading sake and shochu professionals from across the globe to share their insight into the latest market developments and to comment on how the industries are changing. The event will be streamed on YouTube for free for anyone interested in these iconic Japanese beverages.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221215006147/en/
SAKE FUTURE SUMMIT 2022 (Graphic: Business Wire)
The sessions of Sake Future Summit 2022 cover important industry topics such as, resiliency, tradition versus innovation, and sustainability. As the market for both beverages continues to change and evolve, the sessions of the Sake Future Summit are designed to give professionals and enthusiasts alike a view into the current state of sake and shochu and their potential futures.
The 8 sessions of the Sake Future Summit 2022 are as follows:
Day 1
The Global Transformation of Sake
Bringing Sake into the American Mainstream
News from Shochu Land
Traditions and Sustainability in the World of Sake and Honkaku Shochu
Day 2
The Current State of the Sake Industry
Shochu as a Global Beverage
The Cutting Edge Sake & Food Pairing
Challenging Tradition and Innovation in the Sake Market
Event details and the latest session information can be found at: https://sakefuturesummit.com/
*(Note that sessions and speakers are subject to change).
For More Information
- Send media inquiries and additional information requests to: sakefuturesummit2022[at]export-japan[dot]co[dot]jp
About JSS
The Japan Sake and Shochu Makers Association (JSS) is a non-profit organization that consists of sake and shochu producers throughout Japan. Our members include producers of sake, honkaku shochu, awamori, and hon mirin. As of March 2020, JSS is affiliated with 1,696 members, which include 1,410 sake breweries, 273 shochu distilleries, and 13 mirin makers under 47 regional associations.
Japan Sake and Shochu Makers Association SNS links are as follows:
FB: https://www.facebook.com/japansakeshochu
IG: https://www.instagram.com/japansakeshochu_en/
YouTube: https://www.youtube.com/user/JapanSakeOfficial
Twitter: https://twitter.com/jss_sake_en
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221215006147/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom